ResearcherShanghai Medical College of Fudan UniversityNo recent work listed
Hao Chen
Matched on ORCID iD 0000-0001-9595-1842; OpenAlex author ID A5100353503. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper
Papers 3
- Sinapic acid inhibits pancreatic cancer proliferation, migration, and invasion via downregulation of the AKT/Gsk-3β signal pathway. First author DOI 10.1002/ddr.21904↗
- Hic-5 in pancreatic stellate cells affects proliferation, apoptosis, migration, invasion of pancreatic cancer cells and postoperative survival time of pancreat… Co-author DOI 10.1016/j.biopha.2019.109355↗
- A novel scoring system based on hemostatic parameters predicts the prognosis of patients with advanced pancreatic cancer. Last author DOI 10.1016/j.pan.2018.12.010↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Wenguang Fu · 2 shared papers, 2020–2022 · strength 0.25
- Paper Sinapic acid inhibits pancreatic cancer proliferation, migration, and invasion via downregulation of the AKT/Gsk-3β sig… DOI 10.1002/ddr.21904↗
- Paper Hic-5 in pancreatic stellate cells affects proliferation, apoptosis, migration, invasion of pancreatic cancer cells and… DOI 10.1016/j.biopha.2019.109355↗
- Zhiwei Huang · 1 shared paper, 2022 · strength 0.15
- Peng Tan · 1 shared paper, 2022 · strength 0.15
- Zhongqiu Yang · 1 shared paper, 2020 · strength 0.11
- Ankang Wang · 1 shared paper, 2020 · strength 0.11
- Baolin Qian · 1 shared paper, 2020 · strength 0.11
- Qiu Li · 1 shared paper, 2020 · strength 0.11
- Lu-Ming Liu · 1 shared paper, 2019 · strength 0.10
- Yong-Qiang Hua · 1 shared paper, 2019 · strength 0.10
- Hui-Feng Gao · 1 shared paper, 2019 · strength 0.10
- Zhen Chen · 1 shared paper, 2019 · strength 0.10
- Ke Zhang · 1 shared paper, 2019 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.